A novel

Francesco Lechi, Luke R Odell, Olivia Wegrzyniak, Lorenzo J I Balestri, Olof Eriksson, Jonas Eriksson

Abstract read

In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francesco LechiScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Dag Hammarskjölds Väg 14C, 3tr , SE-751 83, Uppsala, Sweden.

Luke R OdellDepartment of Medicinal Chemistry, Uppsala University, 751 23, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-7658-5103

Olivia WegrzyniakScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Dag Hammarskjölds Väg 14C, 3tr , SE-751 83, Uppsala, Sweden.

Lorenzo J I BalestriDepartment of Medicinal Chemistry, Uppsala University, 751 23, Uppsala, Sweden.

Olof ErikssonScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Dag Hammarskjölds Väg 14C, 3tr , SE-751 83, Uppsala, Sweden. olof.eriksson@ilk.uu.se.ORCID http://orcid.org/0000-0002-2515-8790

Jonas ErikssonPET Center, Uppsala University Hospital, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMonoclonal antibodies, engineered protein scaffolds, and peptides are increasingly important in therapy and diagnostics owing to their high specificity and affinity. Recent advances have enabled radiolabelling of such compounds with fluorine-18 in aqueous solution at room temperature via conjugation of [

resultsThe radiochemical yield for [

conclusionThe novel tetrazine prosthetic group [

Indexed as

18F-labellingBiomolecule-PETIEDDA reactionTetrazine

Identifiers

PMID41697612

DOI10.1186/s41181-026-00430-6

PMCPMC12929760

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.